BIOspektrum,
Journal Year:
2023,
Volume and Issue:
29(7), P. 755 - 757
Published: Nov. 1, 2023
Abstract
Chronic
respiratory
diseases
are
one
of
the
most
common
causes
death
globally.
Biomimetic
lung-on-chip
(Lung
Chip)
technologies,
as
powerful
preclinical
in
vitro
models,
have
been
developed
to
mimic
physiological
conditions
human
lungs.
Lung
Chips
rapidly
emerging
promising
and
feasible
alternative
animal
experimentation
pharmaceutical
research.
Herein,
I
briefly
present
latest
advancements
Chips,
well
our
contributions
this
field
Nature Communications,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: April 9, 2025
Within
the
human
lung,
interactions
between
alveolar
epithelial
cells
and
resident
macrophages
shape
lung
development
function
in
both
health
disease.
To
study
these
processes,
we
develop
a
co-culture
system
combining
pluripotent
stem
cell-derived
organoids
induced
to
create
functional
environment,
termed
assembloids.
Using
single-cell
RNA
sequencing
analyses,
identify
type
2-like
producing
GM-CSF,
which
supports
macrophage
tissue
adaptation,
macrophage-like
that
secrete
interleukin-1β
interleukin-6,
express
surfactant
metabolism
genes,
demonstrate
core
immune
functions.
In
response
injury,
efficiently
eliminate
damaged
absorb
oxidized
lipids.
Exposure
bacterial
components
or
infection
with
Mycobacterium
tuberculosis
reveals
assembloids
replicate
key
aspects
of
respiratory
defense.
These
findings
highlight
potential
as
platform
investigate
development,
immunity,
Pharmaceutics,
Journal Year:
2023,
Volume and Issue:
15(11), P. 2582 - 2582
Published: Nov. 3, 2023
Airway
mucus
dysfunction
and
impaired
immunological
defenses
are
hallmarks
of
several
lung
diseases,
including
asthma,
cystic
fibrosis,
chronic
obstructive
pulmonary
mostly
causative
factors
in
bacterial-biofilm-associated
respiratory
tract
infections.
Bacteria
residing
within
the
biofilm
architecture
pose
a
complex
challenge
clinical
settings
due
to
their
increased
tolerance
currently
available
antibiotics
host
immune
responses,
resulting
infections
with
high
recalcitrance
rates
morbidity
mortality.
To
address
these
unmet
needs,
potential
anti-biofilm
therapeutic
strategies
being
developed
effectively
control
bacterial
biofilm.
This
review
focuses
on
recent
advances
development
application
nanoparticulate
drug
delivery
systems
for
treatment
biofilm-associated
infections,
especially
addressing
barriers
concern
accessibility
various
types
nanoparticles
used
combat
biofilms.
Understanding
obstacles
facing
biofilms
nanoparticle-based
approaches
combatting
may
encourage
researchers
explore
promising
modalities
Advanced Healthcare Materials,
Journal Year:
2024,
Volume and Issue:
14(4)
Published: Dec. 15, 2024
Soft
nano-
and
microfiber-based
polymer
scaffolds
bear
enormous
potential
for
their
use
in
cell
culture
tissue
engineering
since
they
mimic
natural
collagen
structures
may
thus
serve
as
biomimetic
adhesive
substrates.
They
have,
however,
so
far
been
restricted
to
small-scale
production
research
labs
with
high
batch-to-batch
variation.
are
commonly
produced
via
electrospinning
or
melt
electrowriting
delicate
nature
poses
obstacles
detachment,
storage,
transportation.
This
study
focuses
on
overcoming
challenges
the
throughput
practical
handling,
introducing
new
methods
reproducibly
prepare
such
suitable
quantitative
applications.
Attention
is
given
seamless
handling
transfer
of
samples
without
compromising
structural
integrity.
Challenges
detaching
fibers
damage
well
transport
addressed.
Cell
studies
demonstrate
methodological
advantages,
emphasizing
standardized
testing
biological
readouts
these
fiber
materials.
The
developed
applicable
across
various
approaches
can
essentially
contribute
utilization
laboratory
commercial
Nanoscale,
Journal Year:
2024,
Volume and Issue:
16(23), P. 10880 - 10900
Published: Jan. 1, 2024
Being
a
vital
organ
exposed
to
the
external
environment,
lung
is
susceptible
plethora
of
pathogens
and
pollutants.
This
reflected
in
high
incidences
chronic
respiratory
diseases,
which
remain
leading
cause
mortality
world-wide
pose
persistent
global
burden.
It
thus
paramount
importance
improve
our
understanding
these
pathologies
provide
better
therapeutic
options.
necessitates
development
representative
physiologically
relevant
vitro
models.
Advances
bioengineering
have
enabled
sophisticated
models
that
not
only
capture
three-dimensional
architecture
cellular
environment
but
also
incorporate
dynamics
local
biophysical
stimuli.
However,
such
complex
require
novel
approaches
reliable
characterization.
Within
this
review
we
explore
how
3D
bioprinting
nanoparticles
can
serve
as
multifaceted
tools
develop
dynamic
4D
printed
facilitate
their
characterization
context
pulmonary
fibrosis
breast
cancer
metastasis.
International Journal of Extreme Manufacturing,
Journal Year:
2023,
Volume and Issue:
5(4), P. 045502 - 045502
Published: Aug. 11, 2023
Abstract
Lung
diseases
associated
with
alveoli,
such
as
acute
respiratory
distress
syndrome,
have
posed
a
long-term
threat
to
human
health.
However,
an
in
vitro
model
capable
of
simulating
different
deformations
the
alveoli
and
suitable
material
for
mimicking
basement
membrane
are
currently
lacking.
Here,
we
present
innovative
biomimetic
controllable
strain
(BCSM)
at
air–liquid
interface
(ALI)
reconstruct
alveolar
respiration.
The
BCSM
consists
high-precision
three-dimensional
printing
melt-electrowritten
polycaprolactone
(PCL)
mesh,
coated
hydrogel
substrate—to
simulate
important
functions
(such
stiffness,
porosity,
wettability,
ALI)
microenvironments,
seeded
pulmonary
epithelial
cells
vascular
endothelial
on
either
side,
respectively.
Inspired
by
papercutting,
was
fabricated
plane
while
it
operated
three
dimensions.
A
series
topological
structure
designed
control
various
local-area
strain,
varied
deformation.
Lopinavir/ritonavir
could
reduce
Lamin
expression
under
over-stretch
condition,
which
might
be
effective
preventing
ventilator-induced
lung
injury.
lung-unit
has
broader
application
prospects
alveoli-related
research
future,
drug
toxicology
metabolism.
Journal of Drug Delivery Science and Technology,
Journal Year:
2023,
Volume and Issue:
82, P. 104316 - 104316
Published: Feb. 25, 2023
Mechanical
forces,
which
are
crucial
for
most
downstream
signaling
pathways
in
lung
(patho-)physiology,
may
also
regulate
the
efficacy
of
drugs.
We
investigated
role
mechanical
forces
on
effectiveness
inhaled
and
systemic
(oral)
administration
an
anti-fibrosis
drug.
established
induced
triple
coculture
fibrosis
model
a
tight
alveolar
endothelial-epithelial
barrier
combined
with
pro-fibrotically
stimulated
primary
fibroblasts
derived
from
healthy
donors
compared
it
to
analogous
idiopathic
pulmonary
(IPF)
patients
(innate
IPF
model).
The
3D
vitro
models
were
biomimetic,
stretchable
basement
(BETA)
membrane
cultured
at
air-liquid
interface
(ALI).
These
treated
FDA-approved
drug
(oral
aerosolized
application
Nintedanib)
under
static
dynamic
culture
conditions
–
including
cyclic
stretch
medium-flow
shear
stress
leveraging
our
advanced
millifluidic
CIVIC
mini-lung
technology.
Fibrosis
markers
characterized
by
protein
immunofluorescence
analysis
supplemented
real-time
measurement
compliance
as
functional
assay.
Nintedanib
shows
more
potent
anti-inflammatory
(IL1β,
IL-6,
IL8)
anti-fibrotic
(αSMA,
soluble
deposited
(type
I)
collagen,
compliance)
effects
both
delivery
methods.
Mechanotransduction
enhanced
restoration
phenotypes
after
delivery,
indicated
surfactant
C
Yes-associated
levels.
Our
findings
suggest
that
plays
Nintedanib.
Albeit
Nintedanib's
potency
routes
is
similar,
has
lower
off-target
dose
fraction
than
oral
application.
Thus,
showed
superior
therapeutic
index
Advanced Functional Materials,
Journal Year:
2024,
Volume and Issue:
34(46)
Published: Aug. 16, 2024
Abstract
Lung‐on‐chips
(LoCs)
are
advanced
microsystems
designed
to
culture
pulmonary
cells
under
physiologically
relevant
conditions,
including
air–liquid
interface,
cell
stretch,
and
shear
stress.
As
the
most
promising
preclinical
models,
LoCs
aimed
reduce
ultimately
replace
conventional
ineffective
animal
studies.
Biomimetic
functional
lead
more
translational
studies
that
effectively
address
unmet
needs
across
therapeutic
areas.
A
variety
of
cell‐
scaffold‐based
techniques
employed
establish
biomimetic
models
closely
resemble
their
in
vivo
counterparts,
which
is
a
challenging
yet
critical
aspect
LoCs.
Herein,
challenges
encountered
discussed,
future
perspectives
toward
higher
biomimicry
using
biofabrication
approaches
explored.
Advanced Materials Technologies,
Journal Year:
2024,
Volume and Issue:
9(20)
Published: July 10, 2024
Abstract
Transwell‐based
airway
models
have
become
increasingly
important
in
studying
the
effects
of
respiratory
diseases
and
drug
treatment
at
air–liquid
interface
lung
epithelial
barrier.
However,
underlying
mechanisms
tissue
cell
level
often
remain
unclear,
as
transwell
inserts
feature
limited
live‐cell
imaging
compatibility.
Here,
a
novel
microfluidic
platform
is
reported
for
cultivation
transwell‐based
tissues
providing
possibility
to
alternate
between
liquid–liquid
interfaces.
While
recapitulates
physiological
conditions
model,
enables
live
high
spatiotemporal
resolution.
The
plastics‐based
insertion
recuperation
inserts,
which
allows
analysis
under
standardized
well
plate
conditions.
device
used
monitor
infections
Pseudomonas
aeruginosa
human
stem‐cell‐derived
bronchial
tissue.
progression
P.
infection
real‐time
resolution
continuously
imaged,
provides
insights
into
bacterial
spreading
invasion
on
apical
surface,
breaching
destruction
over
time.
culture
system
powerful
tool
visualize
elucidate
key
processes
developing
facilitate
testing
development.